BioLife Solutions Balance Sheet Health
Financial Health criteria checks 4/6
BioLife Solutions has a total shareholder equity of $333.4M and total debt of $24.3M, which brings its debt-to-equity ratio to 7.3%. Its total assets and total liabilities are $401.6M and $68.2M respectively.
Key information
7.3%
Debt to equity ratio
US$24.30m
Debt
Interest coverage ratio | n/a |
Cash | US$45.27m |
Equity | US$333.41m |
Total liabilities | US$68.20m |
Total assets | US$401.60m |
Recent financial health updates
Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?
Mar 12Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?
Aug 11Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?
May 06Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?
Jan 10BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?
Sep 27Recent updates
Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%
May 14Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher
May 13Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?
May 11Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?
Mar 12BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price
Feb 19BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion
Dec 19Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term
Aug 17Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?
Aug 11Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?
May 06Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?
Feb 22Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?
Jan 10Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?
Dec 10BioLife: What The Future Holds
Oct 19BioLife Solutions COO Roderick de Greef to retire
Oct 03BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?
Sep 27BioLife Solutions GAAP EPS of -$1.71 misses by $1.50, revenue of $40.5M beats by $1.33M
Aug 09BioLife Solutions: Sell-Side Posture Overly Optimistic, Rate Neutral
Jul 29Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?
Jun 15BioLife: Can This Company Successfully Turn Around?
Apr 18Temporary Setbacks At BioLife
Mar 02Financial Position Analysis
Short Term Liabilities: BLFS's short term assets ($111.7M) exceed its short term liabilities ($38.7M).
Long Term Liabilities: BLFS's short term assets ($111.7M) exceed its long term liabilities ($29.5M).
Debt to Equity History and Analysis
Debt Level: BLFS has more cash than its total debt.
Reducing Debt: BLFS's debt to equity ratio has increased from 0% to 7.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BLFS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BLFS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.